- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05963152
Resistance Exercise and Cognition in People With Type 1 Diabetes
September 7, 2023 updated by: Dr. Ebaa Al Ozairi, Dasman Diabetes Institute
The Effects of Resistance Exercise on Cognition in People With Type 1 Diabetes: a Randomised Controlled Trial
The aim of the current study is to determine the effects of resistance exercise on performance of the Paced Auditory Serial Addition Test and the Colour Trails Test.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ebaa AlOzairi
- Phone Number: 3111 +965 22242999
- Email: ebaa.alozairi@dasmaninstitute.rog
Study Locations
-
-
-
Kuwait City, Kuwait, 15462
- Recruiting
- Dasman Diabetes Institute
-
Contact:
- Ebaa AlOZairi
-
Principal Investigator:
- Ebaa AlOzairi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Physician confirmed type 1 diabetes for at least 1 year
- Stable insulin therapy for 3 months prior to the study
Exclusion Criteria:
- BMI of 45 or higher
- BP of 160/100mmHg or higher
- autonomic neuropathy
- severe proliferative retinopathy
- joint or limb injuries preventing weight-bearing activity
- autonomic neuropathy
- severe proliferative retinopathy
- any other medical condition that prevents participants from exercising safely.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Habitual Physical Activity
|
Participants will be asked to maintain their normal activity levels
|
|
Experimental: Morning exercise
Exercise training between 6-10am
|
Between 6-10am participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)
|
|
Experimental: Afternoon exercise
Exercise training between 4-8pm
|
Between 4-8pm participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chronic change in Paced Auditory Serial Addition Test (PASAT) score
Time Frame: Change from baseline to 12 weeks
|
Measured using the standardised Paced Auditory Serial Addition Test (PASAT) score ranging from 0-60 with a higher score meaning a better outcome
|
Change from baseline to 12 weeks
|
|
Chronic change in Colour Trails Test score
Time Frame: Change from baseline to 12 weeks
|
Measured using the standardised Colour Trails Test, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
|
Change from baseline to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline acute change in Paced Auditory Serial Addition Test (PASAT) score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 1
|
Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the first exercise session, score ranging from 0-60 with a higher score meaning a better outcome
|
Change from before (0 hour) to 1 hour post exercise during week 1
|
|
12 week acute change in Paced Auditory Serial Addition Test (PASAT) score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 12
|
Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the last exercise session, score ranging from 0-60 with a higher score meaning a better outcome
|
Change from before (0 hour) to 1 hour post exercise during week 12
|
|
Baseline acute change in Colour Trails Test score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 1
|
Measured using the standardised Colour Trails Test during the first exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
|
Change from before (0 hour) to 1 hour post exercise during week 1
|
|
12 week acute change in Colour Trails Test score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 12
|
Measured using the standardised Colour Trails Test during the last exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
|
Change from before (0 hour) to 1 hour post exercise during week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2023
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
July 7, 2023
First Submitted That Met QC Criteria
July 18, 2023
First Posted (Actual)
July 27, 2023
Study Record Updates
Last Update Posted (Actual)
September 8, 2023
Last Update Submitted That Met QC Criteria
September 7, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RA HM-2023-010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on type1diabetes
-
Institut de Recherches Cliniques de MontrealRecruiting
-
Silesian Centre for Heart DiseasesThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedtype1diabetesPoland
-
Rabin Medical CenterThe Leona M. and Harry B. Helmsley Charitable Trust; DreaMed DiabetesRecruiting
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType1diabetesUnited States
-
Vastra Gotaland RegionCompletedType1diabetesSweden
-
Vastra Gotaland RegionActive, not recruitingType1diabetes | Psychology Functional BehaviorSweden
-
Kaiser PermanenteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emory...Completed
Clinical Trials on Habitual Physical Activity
-
Loughborough UniversityCompletedInflammation | Physical Activity | Central ObesityUnited Kingdom
-
University of BirminghamMaastricht UniversityCompletedSedentary LifestyleUnited Kingdom
-
University of ExeterRecruitingPhysical Function | Obesity & Overweight | Muscle Mass and StrengthUnited Kingdom
-
University of TorontoRecruitingSarcopenia | Aging | Sedentary Behavior | Amino Acids | Dietary ProteinCanada
-
University of TorontoRecruitingPhysical Inactivity | Resistance Exercise | Amino Acids | Dietary ProteinCanada
-
Dasman Diabetes InstituteRecruiting
-
University of ExeterWithdrawn
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Centre Hospitalier Universitaire DijonWithdrawn